Fisher bioservices, INC.; HHSN261201600006I;DTP-16-027; DTP r & d can# 8422741; title: registration, storageand distribution of chemicals and drugs for pre-clinical discovery, evaluation and…

Ended Awarded Last action

Contract number
HHSN26100001
Awardee
Awarding agency
Obligated
$11,158,266

Award facts

Contract value 100% obligated
$11,158,265.73 Current and potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Rockville, MD 20850, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00013 · FY26 UDO initiative registration, storage and distribution of chemicals and drugs for pre-clinical discovery evaluation and development -$8,770
Other Administrative Action P00012 $87,236
Other Administrative Action P00011 $16,573
Other Administrative Action P00010 $0
Other Administrative Action P00009 · Registration, storage and distribution of chemicals and drugs for pre-clinical discovery evaluation and development -$15,895
Exercise an Option P00008 · Pursuant to far 43.103(a)(3) and far 52.217-6, the purpose of modification eight is to exercise option five additional equipment, add funds to the task order,… $22,711
Exercise an Option P00007 · Pursuant to far 43.103(a)(3) and far 52.217-9, the purpose of modification seven is to exercise option period four, add funds to the task order, extend the… $2,351,114
Other Administrative Action P00006 · Period of performance remains unchanged: 03/01/2019 through 02/29/2020 $0
Exercise an Option P00005 $2,277,231
Exercise an Option 4 $2,213,196
Other Administrative Action 3 $0
Other Administrative Action 2 $0
Other Administrative Action 1 · Title: registration, storage and distribution of chemicals and drugs for pre-clinical discovery, evaluation and development; period of performance: 03/01/2017… $2,136,305
Original award $2,078,564
Show all 14

About this award

The National Cancer Institute issued a delivery order to Fisher Bioservices Inc., Clinical Trials Division, on March 1, 2016, under a cost-plus-fixed-fee pricing structure, with a ceiling value of $11,158,265.73 for registration, storage, and distribution of chemicals and drugs for pre-clinical discovery, evaluation, and development.

The parent vehicle is a single-award indefinite delivery contract within the National Cancer Institute's research infrastructure portfolio. Place of performance is Rockville, Maryland. The order's ultimate completion date is November 9, 2023.

Service Contract Inventory reporting shows labor invoiced across four fiscal years: FY2020 at $3.1 million, FY2021 at $1.3 million with 3.2 FTEs and 6,668 contractor hours at a derived government-paid rate of $196.15 per hour, FY2022 at $91 thousand, and FY2023 at $11.2 million. Fisher Bioservices self-performed all reported hours with no subcontractor involvement in FY2023.

Description

Fisher bioservices, INC.; HHSN261201600006I;DTP-16-027; DTP r & d can# 8422741; title: registration, storageand distribution of chemicals and drugs for pre-clinical discovery, evaluation and development; project: NCI-car

Quick answers

Who was awarded contract HHSN26100001?

HHSN26100001 was awarded to Fisher Bioservices Inc. by National Cancer Institute (National Institutes of Health) on March 1, 2016.

How much is contract HHSN26100001 worth?

The government has obligated $11,158,266 on HHSN26100001.

Is contract HHSN26100001 an order under another contract?

Yes. HHSN26100001 is a delivery order under HHSN261201600006I, an indefinite delivery contract.

Was contract HHSN26100001 competed?

The extent of competition for HHSN26100001 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award